Latham, Cooley Attys 'Cautiously Optimistic' On Biotech IPOs
Attorneys from two law firms that guided the first biotech initial public offering of 2024 have "cautious optimism" about the public market for life sciences companies this year and say that investor...To view the full article, register now.
Already a subscriber? Click here to view full article